DAZRAY Trademark

Trademark Overview

On Tuesday, April 5, 2011, a trademark application was filed for DAZRAY with the United States Patent and Trademark Office. The USPTO has given the DAZRAY trademark a serial number of 85286718. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 6, 2014. This trademark is owned by Glaxo Group Limited. The DAZRAY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
dazray

General Information

Serial Number85286718
Word MarkDAZRAY
Filing DateTuesday, April 5, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 6, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Pseudo MarkDAZE RAY

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 8, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, October 6, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 6, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, February 28, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 27, 2014EXTENSION 5 GRANTED
Monday, February 17, 2014EXTENSION 5 FILED
Monday, February 17, 2014TEAS EXTENSION RECEIVED
Tuesday, September 10, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2013EXTENSION 4 GRANTED
Tuesday, August 27, 2013EXTENSION 4 FILED
Tuesday, August 27, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, March 16, 2013EXTENSION 3 GRANTED
Thursday, February 28, 2013EXTENSION 3 FILED
Thursday, March 14, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 28, 2013TEAS EXTENSION RECEIVED
Wednesday, August 29, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 28, 2012EXTENSION 2 GRANTED
Thursday, August 23, 2012EXTENSION 2 FILED
Tuesday, August 28, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 23, 2012TEAS EXTENSION RECEIVED
Saturday, January 28, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 26, 2012EXTENSION 1 GRANTED
Thursday, January 26, 2012EXTENSION 1 FILED
Thursday, January 26, 2012TEAS EXTENSION RECEIVED
Tuesday, August 30, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 5, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2011PUBLISHED FOR OPPOSITION
Thursday, May 26, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 24, 2011ASSIGNED TO EXAMINER
Saturday, April 9, 2011NOTICE OF PSEUDO MARK MAILED
Friday, April 8, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 8, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

dazray pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological